Evidence map›Paper›PMID 41459733›Full record

ArticleDisease models & mechanisms2025

Disease Models & Mechanisms: a short history of supporting early-career researchers.

Rachel Hackett

Abstract readHistorical ArticleEditorial
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Company of Biologists: a century in review.Disease models & mechanisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rachel HackettThe Company of Biologists, Bidder Building, Station Road, Histon, Cambridge CB24 9LF, UK.ORCID 0000-0002-7511-3953

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scope of Disease Models & Mechanisms (DMM) encompasses different communities - clinicians, basic researchers, translational scientists, patients and their advocates and families, as well as many different disease areas and model systems used to interrogate mechanism and possible therapy. Since its launch, DMM has maintained a commitment to supporting the next generation of scientists, supported by its publisher, the not-for-profit The Company of Biologists. Such initiatives include First Person interviews, Conference Travel Grants, Travelling Fellowships and the annual Outstanding Paper Prize. In this Editorial, we trace the history of the support offered by DMM, with a particular focus on the hugely popular Conference Travel Grants, and highlight testimonials from grant recipients.

Indexed as

Research PersonnelAnimalsHistory, 20th CenturyHistory, 21st CenturyHumansResearch Support as Topic

Identifiers

PMID41459733
PMCPMC12805639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.